Beta · prototype— This site is under construction: rankings, texts and features change every week.

Anaconda Biomed

Active#21 in Spain

Stroke thrombectomy devices

Founded2015
HQSant Quirze del Vallès
RaisedUndisclosed total
Last roundEquity round · Sep 2026
Country of originSpainListed in the Spain ranking
Where would you invest?SpainJurisdiction as cited by the ranking

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Spain · all sectorsTop 50#21Edition 0 – beta · October 20263 Nov 2026
Rank historyOct 2026 · #21First edition: no movements yet.

Estimated valuation

AI · Spain ranking
≈ USD 290MUSD 240–370M · Hundreds of M$ High confidence
Anchor
Last known equity round: Equity round · USD 57M · Sep 2026
AI adjustment
None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

Undisclosed total raised in total
DateRoundAmountTypeInvestors
Sep 2026Equity roundUSD 57M (EUR 49M)EquityOmega Funds, COFIDES, Asabys, Ysios Capital

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Anaconda Biomed as a PDF, on one of three angles only:

ValuationWhat is Anaconda Biomed worth?
Versus competitorsIs #21 the right rank?
Who should acquire itStrategic buyers, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in Spain

Full Spain ranking →

Investors in Anaconda Biomed: Omega Funds · COFIDES · Asabys · Ysios Capital

Last updated: Oct 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.